Company Number: 12669358

Analysis Date: 2025-07-20 15:47 UTC

Financial Health Assessment of Pharmaplace Ltd

---

1. Financial Health Score: C+

Explanation:
Pharmaplace Ltd demonstrates a moderate financial position with some positive indicators such as a healthy increase in net current assets and net assets in 2023 compared to prior years. However, the company carries significant long-term liabilities which dilute overall net asset strength. The micro-entity scale and limited equity base mean the company is vulnerable to external shocks but is currently stable with improving liquidity.

---

2. Key Vital Signs

Metric	2023 Value	Interpretation
Fixed Assets	£56,252	Stable investment in long-term assets, indicating steady infrastructure or equipment base.
Current Assets	£163,941	Substantial increase, suggesting improved liquidity or stock/debtor management.
Current Liabilities	£49,223	Well covered by current assets; positive short-term liquidity.
Net Current Assets (Working Capital)	£114,718	Strong working capital signals healthy operational liquidity ("healthy cash flow").
Long-term Liabilities	£144,730	Significant debt or obligations due beyond one year; potential symptom of financial leverage.
Net Assets (Equity)	£24,590	Positive but modest net worth, indicating the company has some buffer but limited capital strength.
Share Capital	£10.00	Very low share capital; company relies mostly on retained earnings and external financing.
Average Number of Employees	1	Very small workforce, consistent with micro-entity status, but may limit operational capacity.

Additional Notes:

• The company's net current assets have increased substantially from £32,365 in 2022 to £114,718 in 2023, indicating improved short-term financial health.
• However, long-term liabilities have nearly doubled from approximately £74,730 in 2022 to £144,730 in 2023, which may be a sign of increased borrowing or deferred obligations.
• Net assets increased from £13,800 in 2022 to £24,590 in 2023, showing an improved equity position but still relatively low.
• The company remains a micro-entity, with limited reporting obligations and scale, which limits the depth of publicly available financial data.

---

3. Diagnosis: Financial Condition Assessment

Pharmaplace Ltd is currently in a stable but cautious financial condition. The "vital signs" show a business with improving liquidity and operational cash flow, evidenced by the substantial growth in current assets and working capital. This suggests the company is managing its short-term obligations well and is likely generating or holding more liquid assets.

However, the "symptoms of distress" include the significant increase in long-term liabilities, which raises concerns about future debt servicing and financial risk. The company’s equity base remains quite modest, which limits its shock absorption capacity and ability to invest or expand without external financing.

The very small employee base aligns with the micro-entity status but may constrain growth or operational flexibility. The low share capital indicates the company is capital-light, relying on external funding and internal reserves.

Overall, Pharmaplace Ltd is not in immediate financial distress but exhibits a "watchful wellness" profile—healthy operational cash flow but with financial leverage risks that need monitoring.

---

4. Recommendations

To improve financial wellness and strengthen the company’s financial health, Pharmaplace Ltd should consider the following steps:

1. Manage Long-term Debt Prudently:
   Review the terms and necessity of long-term liabilities. Seek to refinance or reduce debt burden if possible to lower financial risk and interest costs.

2. Strengthen Equity Base:
   Consider increasing share capital or retaining more profits to build a stronger net asset position, improving resilience to economic fluctuations.

3. Optimize Working Capital:
   Maintain or improve current asset quality, ensuring receivables and stock are efficiently managed to sustain the healthy liquidity.

4. Expand Operational Capacity Carefully:
   Given the very small workforce, evaluate whether additional staff or outsourcing could improve productivity without overextending finances.

5. Financial Forecasting and Stress Testing:
   Conduct regular cash flow forecasts and scenario analysis to anticipate potential liquidity crunches or debt servicing challenges.

6. Explore Growth Opportunities:
   With improved liquidity, cautiously explore market expansion or diversification to enhance revenue streams while monitoring financial risks.

---